Diagnostics, Financing

Applied Proteomics in $28 million Series C financing

Posted on 21 August 2013

Tags: , ,

Applied Proteomics announces the closing of its $28 million dollar Series C financing.

With this Series C financing investment, API will begin commercializing its novel diagnostic tools and move closer to achieving its vision of saving lives and reducing healthcare costs through precision medicine.

This round of series C financing was led by Genting Berhad, with existing investors Domain Associates and Vulcan Capital also participating in the financing.

Genting Berhad Chairman and CEO Tan Sri Lim Kok Thay was appointed to the API Board of Directors after the series C financing round.

Related

Report: Diagnostics Partnering Terms and Agreements

Report: Oncology Partnering Terms and Agreements

Report: Colorectal Cancer Partnering

View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value

View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making

View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

View: Current Partnering’s Big Biotech Deal Making Scorecard – latest trends in big biotech deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter - reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Follow us on: LinkedIn Current Partnering | LinkedIn Business Development Network | @Currentpartner on Twitter

Print Friendly, PDF & Email

Leave a Reply